Skip to content

Conforma: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Conforma

BE 0400.131.235
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€1.6m
2024 · -€463,894+€2.1m
Equity
€4.1m
2024 · €2.4m+€1.6m
Cash
€2.8m
2024 · €815,931+€1.9m
Balance sheet total
€16.3m
2024 · €11.9m+€4.4m

Largest movements

2024 to 2025
Assets
  • Cash +€1.9m

    up €1.9m (+237.9%), from €815,931 to €2.8m

    mainly Net result for the year (+€1.6m) and Depreciation (+€1.0m)

  • Tangible fixed assets +€1.8m

    up €1.8m (+48.2%), from €3.8m to €5.6m

    of which Assets under construction and advance payments: +€1.3m

  • Stocks and contracts +€805,379

    up €805,379 (+26.7%), from €3.0m to €3.8m

  • Receivables within one year -€357,142

    down €357,142 (-9.9%), from €3.6m to €3.2m

    of which Trade receivables: -€288,013

Equity and liabilities
  • Profit (loss) carried forward +€1.6m

    up €1.6m (+52.5%), from -€3.1m to -€1.5m

  • Other debts +€1.0m

    new in 2025: €1.0m

  • Debts after one year +€872,107

    up €872,107 (+32.3%), from €2.7m to €3.6m

    of which Financial debts: +€872,107

  • Short-term financial debts +€350,000

    up €350,000 (+17.1%), from €2.1m to €2.4m

  • Current portion of long-term debt +€339,589

    up €339,589 (+62.4%), from €543,844 to €883,433

Income statement
  • Gross operating margin +€1.9m

    up €1.9m (+27.7%), from €7.0m to €8.9m

  • Depreciation -€743,218

    down €743,218 (-42.4%), from €1.8m to €1.0m

  • Financial income -€235,061

    down €235,061 (-86.1%), from €272,854 to €37,793

    of which Non-recurring financial income: -€270,577

  • Staff costs +€144,809

    up €144,809 (+2.6%), from €5.6m to €5.7m

  • Write-downs +€107,775

    new in 2025: €107,775

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€463,894
Gross operating margin +€1.9m
Staff costs -€144,809
Depreciation +€743,218
Write-downs -€107,775
Other operating charges -€54,109
Financial income -€235,061
Financial charges +€18,309
Taxes -€67,835
Result 2025 €1.6m

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€3.3m
Investment -€2.9m
Financing +€1.6m
Cash 2024 €815,931
Net result for the year +€1.6m
Depreciation +€1.0m
Stocks and contracts -€805,379
Receivables within one year +€357,142
Deferred charges and accrued income -€58,977
Trade debts +€102,499
Tax, wage and social debts -€24,141
Other debts +€1.0m
Accrued charges and deferred income +€83,177
Investment in fixed assets (net) -€2.9m
Debts after one year +€872,107
Current portion of long-term debt +€339,589
Short-term financial debts +€350,000
Cash 2025 €2.8m
Every line side by side 62 lines
Line Code 2024 2025 Change %
Total assets 20/58 €11,915,946 €16,272,471 +€4.4m +36.6%
Fixed assets 21/28 €4,465,615 €6,374,189 +€1.9m +42.7%
Intangible fixed assets 21 €696,284 €786,847 +€90,563 +13.0%
Tangible fixed assets 22/27 €3,768,830 €5,586,641 +€1.8m +48.2%
Land and buildings 22 €1,902,285 €2,730,519 +€828,233 +43.5%
Plant, machinery and equipment 23 €1,786,137 €1,535,700 -€250,437 -14.0%
Furniture and vehicles 24 €80,408 €52,455 -€27,953 -34.8%
Assets under construction and advance payments 27 - €1,267,968 +€1.3m
Financial fixed assets 28 €501 €701 +€200 +39.9%
Current assets 29/58 €7,450,331 €9,898,282 +€2.4m +32.9%
Stocks and contracts in progress 3 €3,021,655 €3,827,034 +€805,379 +26.7%
Stocks 30/36 €3,021,655 €3,827,034 +€805,379 +26.7%
Amounts receivable within one year 40/41 €3,590,181 €3,233,039 -€357,142 -9.9%
Trade receivables 40 €3,487,263 €3,199,250 -€288,013 -8.3%
Other amounts receivable 41 €102,919 €33,789 -€69,130 -67.2%
Cash at bank and in hand 54/58 €815,931 €2,756,668 +€1.9m +237.9%
Deferred charges and accrued income 490/1 €22,564 €81,541 +€58,977 +261.4%
Total equity and liabilities 10/49 €11,915,946 €16,272,471 +€4.4m +36.6%
Equity 10/15 €2,440,590 €4,063,972 +€1.6m +66.5%
Contributions 10/11 €2,825,986 €2,825,986 = 0.0%
Capital 10 €2,594,621 €2,594,621 = 0.0%
Issued capital 100 €2,594,621 €2,594,621 = 0.0%
Outside capital 11 €231,365 €231,365 = 0.0%
Share premium 1100/10 €231,365 €231,365 = 0.0%
Revaluation surpluses 12 €361,693 €361,693 = 0.0%
Reserves 13 €2,342,310 €2,342,310 = 0.0%
Non-distributable reserves 130/1 €393,766 €393,766 = 0.0%
Legal reserve 130 €148,736 €148,736 = 0.0%
Other 1319 €245,030 €245,030 = 0.0%
Distributable reserves 133 €1,948,544 €1,948,544 = 0.0%
Profit (loss) carried forward 14 -€3,089,399 -€1,466,018 +€1.6m +52.5%
Amounts payable 17/49 €9,475,356 €12,208,499 +€2.7m +28.8%
Amounts payable after more than one year 17 €2,697,428 €3,569,535 +€872,107 +32.3%
Financial debts 170/4 €797,428 €1,669,535 +€872,107 +109.4%
Other amounts payable 178/9 €1,900,000 €1,900,000 = 0.0%
Amounts payable within one year 42/48 €6,777,928 €8,555,787 +€1.8m +26.2%
Current portion of amounts payable after more than one year 42 €543,844 €883,433 +€339,589 +62.4%
Financial debts 43 €2,050,000 €2,400,000 +€350,000 +17.1%
Credit institutions 430/8 €2,050,000 €2,400,000 +€350,000 +17.1%
Trade debts 44 €2,825,133 €2,927,631 +€102,499 +3.6%
Suppliers 440/4 €2,825,133 €2,927,631 +€102,499 +3.6%
Advances received on contracts in progress 46 €288,655 €288,655 = 0.0%
Taxes, remuneration and social security 45 €1,070,296 €1,046,155 -€24,141 -2.3%
Taxes 450/3 €139,026 €117,927 -€21,099 -15.2%
Remuneration and social security 454/9 €931,270 €928,228 -€3,042 -0.3%
Other amounts payable 47/48 - €1,009,913 +€1.0m
Accrued charges and deferred income 492/3 - €83,177 +€83,177
Remuneration, social security and pensions 62 €5,593,884 €5,738,693 +€144,809 +2.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,754,924 €1,011,705 -€743,218 -42.4%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €107,775 +€107,775
Other operating charges 640/8 €63,297 €117,406 +€54,109 +85.5%
Gross operating margin 9900 €6,981,128 €8,916,466 +€1.9m +27.7%
Operating profit (loss) 9901 -€430,977 €1,940,886 +€2.4m
Financial income 75/76B €272,854 €37,793 -€235,061 -86.1%
Recurring financial income 75 €2,278 €37,793 +€35,515 +1559.3%
Non-recurring financial income 76B €270,577 - -€270,577
Financial charges 65/66B €305,772 €287,462 -€18,309 -6.0%
Recurring financial charges 65 €305,772 €287,462 -€18,309 -6.0%
Profit (loss) for the period before taxes 9903 -€463,894 €1,691,217 +€2.2m
Income taxes 67/77 €0 €67,835 +€67,835 +45223460.0%
Profit (loss) for the period 9904 -€463,894 €1,623,382 +€2.1m
Profit (loss) for the period to be appropriated 9905 -€463,894 €1,623,382 +€2.1m

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.